Prehospital treatment with zalunfiban (RUC-4) in patients with ST- elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial.

Sem A O F Rikken,Abi Selvarajah,Renicus S Hermanides,Barry S Coller,C Michael Gibson,Christopher B Granger,Frédéric Lapostolle,Sonja Postma,Henri van de Wetering, Risco C W van Vliet,Gilles Montalescot,Jurriën M Ten Berg,Arnoud W J van 't Hof

American heart journal（2023）

引用 4|浏览25

暂无评分

摘要

The CELEBRATE trial will assess whether a single prehospital subcutaneous injection of zalunfiban in addition to standard-of-care in patients with STEMI with intent to undergo primary PCI will result in improved clinical outcome.

查看译文

关键词

STEMI,ambulance,glycoprotein IIb/IIIa inhibitor,pre-hospital

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要